These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32156728)

  • 1. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation.
    Raffeiner P; Hart JR; García-Caballero D; Bar-Peled L; Weinberg MS; Vogt PK
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6571-6579. PubMed ID: 32156728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
    Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
    Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
    [No Abstract]   [Full Text] [Related]  

  • 3. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
    Si J; Yu X; Zhang Y; DeWille JW
    Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
    Anderson DA; Murphy TL; Eisenman RN; Murphy KM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
    Chang H; Zhang X; Li B; Meng X
    Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
    Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
    J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient KRAB domain for CRISPRi applications in human cells.
    Alerasool N; Segal D; Lee H; Taipale M
    Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.
    Demma MJ; Hohn MJ; Sun A; Mapelli C; Hall B; Walji A; O'Neil J
    FEBS Lett; 2020 May; 594(10):1467-1476. PubMed ID: 32053209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
    Wahlström T; Belikov S; Arsenian Henriksson M
    Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
    Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
    Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
    Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
    Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
    Popov N; Wahlström T; Hurlin PJ; Henriksson M
    Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1.
    Long J; Galvan DL; Mise K; Kanwar YS; Li L; Poungavrin N; Overbeek PA; Chang BH; Danesh FR
    J Biol Chem; 2020 Nov; 295(47):15840-15852. PubMed ID: 32467232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
    Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
    Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
    Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural aspects of interactions within the Myc/Max/Mad network.
    Nair SK; Burley SK
    Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
    Link JM; Hurlin PJ
    Biochim Biophys Acta; 2015 May; 1849(5):554-62. PubMed ID: 24731854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis.
    Lafita-Navarro MC; Blanco R; Mata-Garrido J; Liaño-Pons J; Tapia O; García-Gutiérrez L; García-Alegría E; Berciano MT; Lafarga M; León J
    Oncotarget; 2016 Oct; 7(43):69536-69548. PubMed ID: 27588501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mad proteins contain a dominant transcription repression domain.
    Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
    Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.